These mutant mice lacking exons 2/3 were chosen specifically because this deletion results in the loss of the putative α3β1 integrin-binding domain of TIMP2 shown to mediate its MMP-independent anti-tumor effects, reviewed in (11). The gene discussed is TIMP2; the disease is neoplasm.